INVEGA TRINZA
NDC 50458-609, paliperidone palmitate, injection, suspension, extended release, from Janssen Pharmaceuticals, Inc.
- Product NDC
- 50458-609
- Status
- Listed
- Labeler
- Janssen Pharmaceuticals, Inc
- Dosage form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA207946
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50458-609 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALIPERIDONE PALMITATE819 mg/2.63mL
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50458-609-01 | 50458060901 | 1 SYRINGE in 1 KIT (50458-609-01) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c39e65d7-fa44-4e4c-8b12-a654d3ed0eaeMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50458-609NADAC price for package 50458060901
GET /v1/drugs/nadac/50458060901
Use it
Look up 50458-609 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50458-609 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50458-609. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.